Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT. (Q38404769)
Jump to navigation
Jump to search
scientific article published on September 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT. |
scientific article published on September 2015 |
Statements
1 reference
Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT. (English)
1 reference
Eugene Braunwald
1 reference
Christopher P Cannon
1 reference
Michael A Blazing
1 reference
Sabina A Murphy
1 reference
Erin A Bohula
1 reference
Andrew M Tershakovec
1 reference
Jing Zhou
1 reference
Jennifer A White
1 reference
1 September 2015
1 reference
1 reference
132
1 reference
13
1 reference
1224-1233
1 reference
Identifiers
1 reference
1 reference